AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL | 2021/17.7/6070 | CIPLA LTD | active | 3 Jun 2029 |
| EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL | 2021/17.7/6073 | CIPLA LTD | active | 3 Jun 2029 |
| EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL | 2021/17.7/6071 | CIPLA LTD | active | 3 Jun 2029 |
| EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, COATED; ORAL | 2021/17.7/6072 | CIPLA LTD | active | 3 Jun 2029 |
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.